Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2024
2 years of board service in total across 1 board, counting each seat separately. Longest: GoodRx Holdings Inc., 2 years.
GoodRx Holdings Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
GoodRx Holdings Inc. June 16, 202699.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 8, 2026 | GoodRx Holdings Inc. | Option exercise | +21,692 | — | — |
| Jun 16, 2026 | GoodRx Holdings Inc. | Grant or award | +73,434 | — | — |
| May 27, 2026 | GoodRx Holdings Inc. | Grant or award | +4,642 | — | — |
| Feb 8, 2026 | IQVIA Holdings Inc. | Grant or award | +16,335 | — | — |
| Feb 8, 2026 | IQVIA Holdings Inc. | Shares withheld for tax | −6,801 | $187.49 | $1,275,119 |
| Jan 1, 2026 | GoodRx Holdings Inc. | Grant or award | +18,251 | — | — |
| Nov 8, 2025 | GoodRx Holdings Inc. | Option exercise | +21,691 | — | — |
| Jun 3, 2025 | GoodRx Holdings Inc. | Grant or award | +57,050 | — | — |
| Feb 10, 2025 | IQVIA Holdings Inc. | Shares withheld for tax | −907 | $206.97 | $187,722 |
| Jan 28, 2025 | IQVIA Holdings Inc. | Grant or award | +6,286 | — | — |
| Jan 28, 2025 | IQVIA Holdings Inc. | Shares withheld for tax | −2,201 | $203.43 | $447,749 |
| Jan 1, 2025 | GoodRx Holdings Inc. | Grant or award | +10,653 | — | — |
| Nov 8, 2024 | GoodRx Holdings Inc. | Grant or award | +1,128 | — | — |
| Nov 8, 2024 | GoodRx Holdings Inc. | Grant or award | +20,503 | — | — |
Questions about Ronald E. Bruehlman
What boards is Ronald E. Bruehlman on?
Ronald E. Bruehlman sits on the board of GoodRx Holdings Inc.
How long has Ronald E. Bruehlman served on boards?
Our records show at least 2 years of board service across 1 board, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.